Viropro, Inc. (VPRO)

[newtechinvestor]

It's a rare occurrence. What I want everyone holding Viropro to never forget is that Intas (a billion dollar Indian Pharmaceutical company) is the controlling shareholder and their reputation was probably in my mind the key to consummating this deal and many more to come.

No business wants to do business with company with shaky background and uncertain financials. Viropro does hold the all important license that will aid in manufacturing biosimilars but in terms of corporate governance and financials it was another pinksheet company. That all changed with acquisition of Biologics Process Development (BPD) from Intas (a licensee of Viropro) and thereby Intas became controlling shareholder or majority holder of Viropro.
http://www.biologicspd.com/
http://www.intaspharma.com/

Viropro has been keeping up with SEC filings, which to my knowledge does not require to so. I believe the company will move to OTB BB soon. I think Viropro management is all business by the way they didn't even release a PR associated with SPPI deal. It's perhaps too early, but I see the company making some serious transformation from developmental company to revenue generating company. Company made board and the management changes and announced a deal with SPPI. Now, that is significant development.